Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction - PubMed (original) (raw)
Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction
Daniel Kellner et al. J Urol. 2006 Aug.
Abstract
Purpose: Unilateral ureteral obstruction is characterized by histopathological changes including interstitial fibrosis, fibroblast specific protein expression, tubular atrophy and apoptosis, and macrophage infiltration. Angiotensin II has been implicated in some of these changes. We examined the effect of angiotensin blockade on markers of renal injury, including fibroblast specific protein expression, fibrosis, apoptosis and macrophage infiltration. We used losartan, an angiotensin II antagonist, in a unilateral ureteral obstruction model and studied animals 3 weeks after unilateral ureteral obstruction, a time at which renal damage is well established.
Materials and methods: Rats underwent unilateral ureteral obstruction and were given either drinking water or losartan for 21 days. Kidneys were harvested and examined for fibrosis (trichrome and the Sircol assay for collagen), apoptosis (TUNEL), and fibroblast specific protein expression and macrophage infiltration (immunohistochemistry).
Results: Unilateral ureteral obstruction was found to induce fibrosis, apoptosis, fibroblast expression and macrophage in the obstructed kidney. Losartan significantly decreased apoptosis and macrophage infiltration in the obstructed kidney. It also decreased fibrosis, as measured by either trichrome staining assessed by a pathologist, the Sircol assay for collagen or fibroblast specific protein expression. However, approximately 50% of the changes were not affected by the current treatment, suggesting that other factors contribute to renal damage in unilateral ureteral obstruction.
Conclusions: We observed the direct contribution of angiotensin II to both apoptotic and cellular transition processes (epithelial mesenchymal transition) and fibrosis in unilateral ureteral obstruction. Because these processes are active not only in unilateral ureteral obstruction, but also in other renal diseases, the value of angiotensin II blockade as an important part of the antifibrotic armamentarium has been confirmed.
Similar articles
- Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction.
Miyajima A, Asano T, Asano T, Yoshimura I, Seta K, Hayakawa M. Miyajima A, et al. J Urol. 2001 May;165(5):1714-8. J Urol. 2001. PMID: 11342962 - Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction.
El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR, Vaughan ED Jr, Poppas DP, Felsen D. El Chaar M, et al. Am J Physiol Renal Physiol. 2007 Apr;292(4):F1291-301. doi: 10.1152/ajprenal.00327.2005. Epub 2006 Dec 12. Am J Physiol Renal Physiol. 2007. PMID: 17164399 - Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?
Miyajima A, Ito K, Asano T, Seta K, Ueda A, Hayakawa M. Miyajima A, et al. J Urol. 2001 Sep;166(3):1124-9. J Urol. 2001. PMID: 11490310 - Biochemical-molecular markers in unilateral ureteral obstruction.
Manucha W. Manucha W. Biocell. 2007;31(1):1-12. Biocell. 2007. PMID: 17665634 Review. - Obstructive nephropathy: towards biomarker discovery and gene therapy.
Chevalier RL. Chevalier RL. Nat Clin Pract Nephrol. 2006 Mar;2(3):157-68. doi: 10.1038/ncpneph0098. Nat Clin Pract Nephrol. 2006. PMID: 16932414 Review.
Cited by
- Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives.
Confalonieri F, Lumi X, Petrovski G. Confalonieri F, et al. Biomedicines. 2023 Jul 12;11(7):1976. doi: 10.3390/biomedicines11071976. Biomedicines. 2023. PMID: 37509613 Free PMC article. - The therapeutic approaches of renal recovery after relief of the unilateral ureteral obstruction: A comprehensive review.
Kaeidi A, Maleki M, Shamsizadeh A, Fatemi I, Hakimizadeh E, Hassanshahi J. Kaeidi A, et al. Iran J Basic Med Sci. 2020 Nov;23(11):1367-1373. doi: 10.22038/ijbms.2020.41984.9926. Iran J Basic Med Sci. 2020. PMID: 33235692 Free PMC article. Review. - Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.
Hu S, Xie H, Luo R, Feng P, Liu Q, Han M, Kong Y, Zou X, Wang W, Li C. Hu S, et al. Front Physiol. 2019 Sep 13;10:1157. doi: 10.3389/fphys.2019.01157. eCollection 2019. Front Physiol. 2019. PMID: 31572210 Free PMC article. - The Key Role of Epithelial to Mesenchymal Transition (EMT) in Hypertensive Kidney Disease.
Seccia TM, Caroccia B, Piazza M, Rossi GP. Seccia TM, et al. Int J Mol Sci. 2019 Jul 21;20(14):3567. doi: 10.3390/ijms20143567. Int J Mol Sci. 2019. PMID: 31330886 Free PMC article. Review. - HRD1 prevents apoptosis in renal tubular epithelial cells by mediating eIF2α ubiquitylation and degradation.
Huang Y, Sun Y, Cao Y, Sun H, Li M, You H, Su D, Li Y, Liang X. Huang Y, et al. Cell Death Dis. 2017 Dec 11;8(12):3202. doi: 10.1038/s41419-017-0002-y. Cell Death Dis. 2017. PMID: 29233968 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources